1887

Chapter 17 : Host Susceptibility

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Host Susceptibility, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap17-1.gif /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap17-2.gif

Abstract:

In this chapter, the term cholera gravis will denote the most severe life-threatening form of the disease, which can be rapidly fatal without treatment. One of the clear messages about cholera is that if the environment is made safer by sound sanitary practices and if good personal hygiene is put in place, the disease largely goes away. Anti-cholera toxin binding (CTB) antibody titers in contact with children's saliva were used to correlate their immune responses to CTB vaccination with nutritional status as part of the intervention arm of the family study mentioned in the chapter. The cholera attack rates were 88% in the heavy users of cannabis and 37% in light users. Because of the extensive use of cannabis-containing products in many areas where cholera is endemic, habitual usage may be a factor in host susceptibility where the risk of intake of contaminated food and water is high. The molecular genetic basis for the group ABO system was elucidated by Yamamoto, who suggested that the ABO markers be designated a histo-blood system, since the genes and their products are also found in many other cell types, e.g., epithelial cells. At present, two major attachment systems are known to be involved in adherence and colonization of animals and humans. The toxin-coregulated pilis (TCPs) share 80% amino acid homology at the amino acid level.

Citation: Richardson S. 1994. Host Susceptibility, p 273-289. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch17

Key Concept Ranking

Outer Membrane Proteins
0.473206
Small Intestine
0.4547567
DNA Restriction Enzymes
0.43816882
0.473206
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818364.chap17
1. Barra, J. L.,, C. G. Monferran,, L. E. Balanzino, and E A. Cumar. 1992. Escherichia coli heat-labile enterotoxin preferentially interacts with blood group A-active glycolipids from pig intestinal mucosa and A- and B-active glycolipids from human red cells compared to H-active glycolipids. Mol. Cell. Biochem. 115:6370.
2. Barua, D.,, and A. S. Paguio. 1977. ABO blood groups and cholera. Ann. Hum. Biol. 4:489492.
3. Bennun, E. R.,, G. A. Roth,, C. G. Monferran,, and F. A. Cumar. 1989. Binding of cholera toxin to pig intestinal mucosa glycosphingolipids: relationship with the ABO blood group system. Infect, lmmun. 57:969974.
4. Cater, R. E.,, n. 1992. Helicobacter (aka Campylobacter) pylori as the major causal factor in chronic hypochlorhydria. Med. Hypoth. 39:367374.
5. Chaudhuri, A.,, and S. De. 1977. Cholera and blood-groups. Lancet ii:404.
6. Clemens, J. D.,, D. A. Sack,, J. R. Harris,, J. Chakraborty,, M. R. Khan,, S. Huda,, F. Ahmed,, J. Gomes,, M. R. Rao,, A.-M. Svennerholm,, and J. Holmgren. 1989. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J. Infect. Dis. 159:770773.
7. Clemens, J. D.,, D. A. Sack,, J. R. Harris,, M. R. Khan,, J. Chakraborty,, S. Chowdhury,, M. R. Rao,, F. R. van Loon,, B. E. Stanton,, M. Yunus,, M. Ali,, M. Ansaruzzaman,, A.-M. Svennerholm,, and J. Holmgren. 1990. Breast feeding and the risk of severe cholera in rural Bangladeshi children. Am. J. Epidemiol. 131:400411.
8. Cover, T. L.,, S. G. Vaughn,, and P. Cao. 1992. Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J. Infec. Dis. 166:10731078.
9. Donta, S. T.,, T. Tomicle,, and R. K. Holmes. 1992. Binding of class U Escherichia coli enterotoxins to mouse Yl and intestinal cells. Infect. Immun. 60:28702873.
10. Dubey, R. S.,, M. Lindblad,, and J. Holmgren. 1990. Purification of El Tor cholera enterotoxins and comparisons with classical toxin. J. Gen. Microbiol. 136:18391847.
11. Elson, C. O. 1992. Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and Ips genes. Infect. Immun. 60:28742879.
12. Elson, C. O.,, and W. Ealding. 1985. Genetic control of the murine immune response to cholera toxin. J. Immunol. 135:930932.
13. Elson, C. O.,, and W. Ealding. 1987. Ir gene control of the murine secretory IgA response to cholera toxin. Eur. J. Immunol. 17:425428.
14. Ernst, L. K.,, V. P. Rajan,, R. D. Larsen,, M. M. Ruff,, and J. B. Lowe. 1989. Stable expression of blood group H determinants and GDP-L-fucose: beta-D-galactoside 2-alpha-L-fucosyltransferase in mouse cells after transfection with human DNA. J. Biol. Chem. 264:34363447.
15. Finkelstein, R. A.,, M. Boesman-Finkelstein,, Y. Chang,, and C. C. Hase. 1992. Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect. Immun. 60:472478.
16. Galen, J. J.,, A. Ketley,, A. Fasano,, S. Richardson,, S. Wasserman,, and J. Kaper. 1992. Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect. Immun. 60:406415.
17. Glass, R. I.,, J. Holmgren,, C. E. Haley,, M. R. Khan,, A.-M. Svennerholm,, B. J. Stoll,, K. M. B. Hossain,, R. E. Black,, M. Yunus,, and D. Barua. 1985. Predisposition for cholera of individuals with O blood group. Am. J. Epidemiol. 121:791796.
18. Glass, R. I.,, J. Holmgren,, M. R. Khan,, K. M. B. Hossain,, M. I. Huq,, and W. B. Greenough. 1984. A randomized, controlled trial of the toxin-blocking effects of B Subunit in family members of patients with cholera. J. Infect. Dis. 149:495500.
19. Glass, R. I.,, A.-M. Svennerholm,, M. R. Khan,, S. Huda,, M. I. Huq,, and J. Holmgren. 1985. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 151:236242.
20. Glass, R. I.,, A. M. Svennerholm,, B. J. Stoll,, M. R. Khan,, S. Huda,, and M. I. Huq. 1989. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine. Pediatr. Infect. Dis. J. 8:105109.
21. Hakomori, S. 1991. Immunochemical and molecular genetic basis of the histo-blood group ABO(H) and related antigen system. Baillieres Clin. Haematol. 4:957974.
22. Hall, R. H.,, G. Losonsky,, A. R D. Silveira, R. K. Taylor, J. J. Mekalanos, N. D. Witham, and M. M. Levine. 1991. Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera. Infect. Immun. 59:25082512.
22a. Hashimoto, Y.,, A. Suzuki,, T. Yamakawa,, N. Miwashita,, and K. Moriwaki. 1983. Expression of GM1 and GDI a in mouse liver is linked to the H-2 complex on chromosome 17. J. Biochem. 94:20432048.
23. Holgersson, J.,, N. Strdmberg,, and M. E. Breimer. 1988. Glycolipids of human large intestine: difference in glycolipid expression related to anatomical localization, epithelial/non-epithelia tissue and the ABO, Le and Se phenotypes of the donors. Biochimie 70:15651574.
24. Jonson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1991. Epitope differences in toxin-coregulated pili produced by classical and El Tor Vibrio cholerae O1. Microb. Pathog. 11:179188.
25. Johnson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1991. Identification of a mannose-binding pilus on Vibrio cholerae El Tor. Microb. Pathog. 11:433441.
26. Jonson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1992. Analysis of expression of toxin-coregulated pili in classical and El Tor Vibrio cholerae O1 in vitro and in vivo. Infect. Immun. 60:42784284.
27. Kaper, J. Personal communication.
28. Katelaris, P. H.,, G. H. K. Hppett,, P. Norbu,, D. G. Lowe,, R. Brennan,, and M. J. G. Farthing. 1992. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut 33:14621466.
29. Lange, S.,, and I. Lonnroth. 1986. Bile and milk from cholera toxin treated rats contain a hormonelike factor which inhibits diarrhea induced by the toxin. Int. Arch. Allergy Appl. Immunol. 79:270275.
30. Levine, M. M.,, D. R. Nalin,, M. B. Rennels,, R. B. Hornick,, S. Sotman,, G. Van Blerk,, T. P. Hughes,, S. O'DonneU,, and D. Barua. 1979. Genetic susceptibility to cholera. 6:369374.
31. Mandel, U.,, T. White,, J. Karkov,, S. Hakomori,, H. Clausen,, and E. Dabelsteen. 1990. Expression of the histo-blood group ABO gene defined gly-cosyltransferases in epithelial tissues. J. Oral Pathol. Med. 19:251256.
32. Moyenuddin, M.,, K. Wachsmuth,, S. H. Richardson,, and W. L. Cook. 1992. Enteropatho-genicity of non-toxigenic Vibrio cholerae O1 for adult mice. Microb. Pathog. 12:451458.
33. Nalin, D. R.,, M. M. Levine,, E. Bergquist,, J. Libonati,, R. J. Levine,, D. Hoover,, J. McLaughlin,, J. Alam,, and R. B. Hornick. 1978. Cholera, non-vibrio cholera, and stomach acid. Lancet ii:856859.
34. Nalin, D. R.,, J. Rhead,, M. Rennels,, S. O'DonneU,, M. M. Levine,, E. Bergquist,, T. Hughes,, and R. B. Hornick. 1978. Cannabis, hypo-chlorhydria, and cholera. Lancet ii:859862.
35. Odelgah, P. G. 1990. Influences of blood group and secretor genes on susceptibility to duodenal ulcer. EastAfr. Med. J. 67:487500.
36. Oriol, R.,, R. Mollicone,, P. Coulin,, A. M. Dalix,, and J. J. Candelier. 1992. Genetic regulation of the expression of ABH and Lewis antigens in tissues. APMISSuppl. 27:2838.
37. Palmer, D. L.,, and S. N. Zaman. 1979. Depression of cell-mediated immunity in cholera. Infect. Immun. 23:2730.
38. Ramirez-Ramos, A.,, R. Gilman,, W. Spira,, S. Recavarren,, J. Watanabe,, R. Leon-Barua,, C. Rodriguez,, C. Guevara,, G. Gago,, J. Bonilla,, J. Cok,, H. Huidobro Ruiz,, E. Gomez,, E. Olivares,, R. Garcia,, G. Garrido Klinge,, G. Vargas,, M. Astete,, M. Valdivia,, and R. Berendson. 1992. Ecology of Helicobacter pylori in Peru: infection rates in coastal, high altitude, and jungle communities. Gut 33:604605.
39. Richardson, S. H.,, J. C. Giles,, and K. S. Kruger. 1984. Sealed adult mice: a new model for enterotoxin evaluation. Infect. Immun. 43:482486.
40. Richardson, S. H.,, and J. V. Kaspar,. 1990. Genetic studies on V. fluvialis and its enterotoxins, p. 159171. In A. E. Pohland et al. (ed.), Microbial, Toxins in Foods and Feeds. Plenum Press, New York.
41. Richardson, S. H.,, M. Kothary,, and T. Sexton,. 1990. H-2 regulated responses to enterotoxins in isolated cells, cell lysates and membranes, p. 235246. In Y. Zinnaka, and R. B. Sack (ed.), Advances in Research on Cholera and Related Diarrheas, vol. 7. KTK Scientific Publishers, Tokyo.
42. Richardson, S. H.,, R. Kuhn,, J. Estrada,, M. J. Black,, and D. Pardi,. 1988. In vivo and in vitro studies on the genetic and cellular control of the response to cholera toxin in inbred mice, p. 297306. In S. Kuwahara, and N. Pierce (ed.), Advances in Research on Cholera and Related Diarrheas, vol. 5. KTK Scientific Publishers, Tokyo.
43. Richardson, S. H.,, and R. E. Kuhn,. 1986. H-2 modulation of cholera enterotoxin effects in SAM: (sealed adult mice), p. 305316. In S. Kuwahara, and N. F. Pierce (ed.), Advances in Research on Cholera and Related Diarrheas, vol. 3. KTK Scientific Publishers, Tokyo.
44. Richardson, S. H.,, and R. E. Kuhn. 1986. Studies on the genetic and cellular control of sensitivity to enterotoxins in the sealed adult mouse model. Infect. Immun. 54:522528.
45. Richardson, S. H.,, T. Sexton,, J. Rader,, and C. Kajs. 1993. The biochemical and genetic basis for the ETS (enterotoxin sensitivity) phenotype in mice. Clin. Infect. Dis. 16(Suppl. 2):S83S91.
46. Richardson, S. H.,, T. Y. Sexton,, C. Kajs,, and J. Rader,. The enterotoxin sensitivity phenotype (ETS) is controlled by host cell ganglioside composition. In Y. Takeda, and R. B. Sack (ed.), Advances in Research on Cholera and Related Diarrheas, vol. 9, in press. KTK Scientific Publishers, Tokyo.
47. Rodman, D. M.,, and S. Zamudio. 1991. The cystic fibrosis heterozygote—advantage in surviving cholera? Med. Hypoth. 36:253258.
48. Sheinfeld, J.,, A. J. Schaffer,, C. Cordon-Cardo,, A. Ragatko,, and W. R. Fair. 1989. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N. Engl. J. Med. 320:773777.
49. Sircar, B. K.,, P. Dutta,, S. P. De,, S. N. Sikdar,, B. C. Deb,, and S. C. Pal. 1981. ABO blood group distributions in diarrhoea cases including cholera in Calcutta. Ann. Hum. Biol. 8:289291.
50. Sugarman, B.,, and S. T. Donta. 1979. Specificity of attachment of certain enterobacteriaccae to mammalian cells. J. Gen. Microbiol. 115:509512.
51. van Loon, F. P.,, J. D. Clemens,, M. Shahrier,, D. A. Sack,, C. B. Stephen,, M. R. Khan,, G. H. Rabbani,, M. R. Rao,, and A. K. Banik. 1990. Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test. J. Clin. Epidemiol. 43:13611367.
52. Walser, B. L.,, R. D. Newman,, A. A. M. Lima,, and R. L. Guerrant. 1992. Pathogen and host differences in bacterial adherence to human buccal epithelial cells in a northeast Brazilian community. Infect. Immun. 60:47934800.
53. Yamamoto, F.,, H. Clausen,, T. White,, J. Marken,, and S. Hakomori. 1900. Molecular genetic basis of the histo-blood group ABO system. Nature (London) 345:229233.

Tables

Generic image for table
Table 1

Evidence linking cholera severity to ABO blood type

Citation: Richardson S. 1994. Host Susceptibility, p 273-289. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch17
Generic image for table
Table 2

CT binding and cAMP accumulation in ETS and ETS cell lines

Citation: Richardson S. 1994. Host Susceptibility, p 273-289. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch17
Generic image for table
Table 3

Effects of preincubation with neuraminidase, LT Da, and LT lib on CT-induced cAMP accumulation in ETS and ETS transformed cells

Citation: Richardson S. 1994. Host Susceptibility, p 273-289. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch17

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error